Drugmaker Alexion to cut 20 pct of jobs

Sept 12 (Reuters) - U.S. drugmaker Alexion Pharmaceuticals Inc said on Tuesday it would lay off about 20 percent of its global workforce in an effort to cut spending.

The company had about 3,100 full-time employees worldwide as of the end of last year.

Alexion also said it would relocate its headquarters to Boston from New Haven, Connecticut by mid-2018. (Reporting by Manas Mishra in Bengaluru; Editing by Sai Sachin Ravikumar)